Serum Glutamine Levels as a Potential Diagnostic Biomarker in Sepsis following Surgery for Peritonitis

10.4077/CJP.2017.BAG495

Chun-Ju Yang；Ting-Shuo Huang；Tung-Liang Lee；Kang-Chung Yang；Shin-Sheng Yuan；Ruey-Hwa Lu；Chung-Ho Hsieh；Yu-Chiau Shyu

glutamine ； peritonitis ； selenium ； sepsis ； surgery

The Chinese Journal of Physiology

60卷6期（2017 / 12 / 31）

320 - 326

英文

Few diagnostic biomarkers for sepsis after emergency peritonitis surgery are available to clinicians, and, thus, it is important to develop new biomarkers for patients undergoing this procedure. We investigated whether serum glutamine and selenium levels could be diagnostic biomarkers of sepsis in individuals recovering from emergency peritonitis surgery. From February 2012 to March 2013, patients who had peritonitis diagnosed at the emergency department and underwent emergency surgery were screened for eligibility. Serum glutamine and selenium levels were obtained at pre-operative, post-operative and recovery time points. The average level of pre-operation serum glutamine was significantly different from that on the recovery day (0.317 ± 0.168 vs. 0.532 ± 0.155 mM, P ＜ 0.001); moreover, serum glutamine levels were unaffected by surgery. Selenium levels were significantly lower on the day of surgery than they were at recovery (106.6 ± 36.39 vs. 130.68 ± 56.98 ng/mL, P = 0.013); no significant difference was found between pre-operation and recovery selenium levels. Unlike selenium, glutamine could be a sepsis biomarker for individuals with peritonitis. We recommend including glutamine as a biomarker for sepsis severity assessment in addition to the commonly used clinical indicators.

1. Health Promotion Administration, Ministry of Health and Welfare. 2012 Leading causes of death in Taiwan, 2013.
2. Alhazzani, W.,Jacobi, J.,Sindi, A.,Hartog, C.,Reinhart, K.,Kokkoris, S.,Gerlach, H.,Andrews, P.,Drabek, T.,Manzanares, W.,Cook, D.J.,Jaeschke, R.Z.(2013).The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials.Crit. Care Med.,41,1555-1564.
3. Andrews, P.J.,Avenell, A.,Noble, D.W.,Campbell, M.K.,Croal, B.L.,Simpson, W.G.,Vale, L.D.,Battison, C.G.,Jenkinson, D.J.,Cook, J.A.(2011).Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients.BMJ,342,d1542.
4. Bloos, F.,Reinhart, K.(2014).Rapid diagnosis of sepsis.Virulence,5,154-160.
5. Bollhalder, L.,Pfeil, A.M.,Tomonaga, Y.,Schwenkglenks, M.(2013).A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation.Clin. Nutr.,32,213-223.
6. Cetinbas, F.,Yelken, B.,Gulbas, Z.(2010).Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome.J. Crit. Care,25,661.e1-661.e6.
7. Chen, Y.C.,Chang, S.C.,Pu, C.,Tang, G.J.(2013).The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in Taiwan.PLoS One,8,e77414.
8. Dellinger, R.P.,Levy, M.M.,Rhodes, A.,Annane, D.,Gerlach, H.,Opal, S.M.,Sevransky, J.E.,Sprung, C.L.,Douglas, I.S.,Jaeschke, R.,Osborn, T.M.,Nunnally, M.E.,Townsend, S.R.,Reinhart, K.,Kleinpell, R.M.,Angus, D.C.,Deutschman, C.S.,Machado, F.R.,Rubenfeld, G.D.,Webb, S.,Beale, R.J.,Vincent, J.L.,Moreno, R.(2013).Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock.Intensive Care Med.,39,165-228.
9. Dos Santos, R.,Viana, M.L.,Generoso, S.V.,Arantes, R.E.,Davisson Correia, M.I.,Cardoso, V.N.(2010).Glutamine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model.JPEN J. Parenter. Enteral Nutr.,34,408-413.
10. Eberhard, O.K.,Haubitz, M.,Brunkhorst, F.M.,Kliem, V.,Koch, K.M.,Brunkhorst, R.(1997).Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.Arthritis Rheum.,40,1250-1256.
11. Forceville, X.,Vitoux, D.,Gauzit, R.,Combes, A.,Lahilaire, P.,Chappuis, P.(1998).Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients.Crit. Care Med.,26,1536-1544.
12. Gabay, C.,Kushner, I.(1999).Acute-phase proteins and other systemic responses to inflammation.N. Engl. J. Med.,340,448-454.
13. Grimble, R.F.(2005).Immunonutrition.Curr. Opin. Gastroenterol.,21,216-222.
14. Gstraunthaler, G.,Landauer, F.,Pfaller, W.(1992).Ammoniagenesis in LLC-PK1 cultures: role of transamination.Am. J. Physiol.,263,C47-C54.
15. Heyland, D.,Muscedere, J.,Wischmeyer, P.E.,Cook, D.,Jones, G.,Albert, M.,Elke, G.,Berger, M.M.,Day, A.G.(2013).A randomized trial of glutamine and antioxidants in critically ill patients.N. Engl. J. Med.,368,1489-1497.
16. Huang, T.S.,Huang, S.S.,Shyu, Y.C.,Lee, C.H.,Jwo, S.C.,Chen, P.J.,Chen, H.Y.(2014).A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.PLoS One,9,e90539.
17. Huang, T.S.,Shyu, Y.C.,Chen, H.Y.,Lin, L.M.,Lo, C.Y.,Yuan, S.S.,Chen, P.J.(2013).Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis.PLoS One,8,e54431.
18. Jang, J.Y.,Shim, H.,Lee, S.H.,Lee, J.G.(2014).Serum selenium and zinc levels in critically ill surgical patients.J. Crit. Care,29,317.e5-8.
19. Jung, B.,Molinari, N.,Nasri, M.,Hajjej, Z.,Chanques, G.,Jean-Pierre, H.,Panaro, F.,Jaber, S.(2013).Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock.Crit. Care,17,R255.
20. Kim, H.(2011).Glutamine as an immunonutrient.Yonsei Med. J.,52,892-897.
21. Levy, M.M.,Artigas, A.,Phillips, G.S.,Rhodes, A.,Beale, R.,Osborn, T.,Vincent, J.L.,Townsend, S.,Lemeshow, S.,Dellinger, R.P.(2012).Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study.Lancet Infect. Dis.,12,919-924.
22. Manzanares, W.,Langlois, P.L.,Heyland, D.K.(2015).Pharmaconutrition with selenium in critically ill patients: what do we know?.Nutr. Clin. Pract.,30,34-43.
23. Meisner, M.,Adina, H.,Schmidt, J.(2006).Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.Crit. Care,10,R1.
24. Meisner, M.,Tschaikowsky, K.,Hutzler, A.,Schick, C.,Schuttler, J.(1998).Postoperative plasma concentrations of procalcitonin after different types of surgery.Intensive Care Med.,24,680-684.
25. Novak, F.,Heyland, D.K.,Avenell, A.,Drover, J.W.,Su, X.(2002).Glutamine supplementation in serious illness: a systematic review of the evidence.Crit. Care Med.,30,2022-2029.
26. Oudemans-Van Straaten, H.M.,Bosman, R.J.,Treskes, M.,Van Der Spoel, H.J.,Zandstra, D.F.(2001).Plasma glutamine depletion and patient outcome in acute ICU admissions.Intensive Care Med.,27,84-90.
27. Rayman, M.P.(2012).Selenium and human health.Lancet,379,1256-1268.
28. Rayman, M.P.(2000).The importance of selenium to human health.Lancet,356,233-241.
29. Reinhart, K.,Meisner, M.(2011).Biomarkers in the critically ill patient: procalcitonin.Crit. Care Clin.,27,253-263.
30. Sakr, Y.,Reinhart, K.,Bloos, F.,Marx, G.,Russwurm, S.,Bauer, M.,Brunkhorst, F.(2007).Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure.Brit. J. Anaesth.,98,775-784.
31. Simon, L.,Gauvin, F.,Amre, D.K.,Saint-Louis, P.,Lacroix, J.(2004).Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.Clin. Infect. Dis.,39,206-217.
32. Soeters, P.B.,Grecu, I.(2012).Have we enough glutamine and how does it work? A clinician's view.Ann. Nutr. Metab.,60,17-26.
33. Sponholz, C.,Sakr, Y.,Reinhart, K.,Brunkhorst, F.(2006).Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.Crit. Care,10,R145.
34. Su, L.,Han, B.,Liu, C.,Liang, L.,Jiang, Z.,Deng, J.,Yan, P.,Jia, Y.,Feng, D.,Xie, L.(2012).Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.BMC Infect. Dis.,12,157.
35. Tang, B.M.,Eslick, G.D.,Craig, J.C.,Mclean, A.S.(2007).Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.Lancet Infect. Dis.,7,210-217.
36. Van Acker, B.A.,Hulsewe, K.W.,Wagenmakers, A.J.,Soeters, P.B.,Von Meyenfeldt, M.F.(2000).Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans.J. Nutr.,130,1566-1571.
37. Wacker, C.,Prkno, A.,Brunkhorst, F.M.,Schlattmann, P.(2013).Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.Lancet Infect. Dis.,13,426-435.
38. Wang, Y.,Jiang, Z.M.,Nolan, M.T.,Jiang, H.,Han, H.R.,Yu, K.,Li, H.L.,Jie, B.,Liang, X.K.(2010).The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials.JPEN J. Parenter. Enteral Nutr.,34,521-529.
39. Wessner, B.,Strasser, E.M.,Spittler, A.,Roth, E.(2003).Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R,S-alpha-lipoic acid on glutathione content of myelomonocytic cells.Clin. Nutr.,22,515-522.
40. Wood, S.M.,Beckham, C.,Yosioka, A.,Darban, H.,Watson, R.R.(2000).β-Carotene and selenium supplementation enhances immune response in aged humans.Integr. Med.,2,85-92.